A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
β Scribed by Taisei Nakamoto; Yoko Murayama; Kenji Oritani; Claude Boucheix; Eric Rubinstein; Makoto Nishida; Fumie Katsube; Kenji Watabe; Shinichi Kiso; Shusaku Tsutsui; Shinji Tamura; Yasuhisa Shinomura; Norio Hayashi
- Publisher
- Springer Japan
- Year
- 2009
- Tongue
- English
- Weight
- 326 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Antitumor effects of antibodies against ganglioside antigens of melanoma have been reported, but neither optimal doses nor mechanisms have been established. ## METHODS. This Phase IB trial of the murine immunoglobulin IgG 3 monoclonal antibody R 24 against disialoganglioside GD3
## Abstract Diffuseβtype gastric carcinomas (GCs) are often difficult to characterize because of contamination of tumor samples by surrounding normal tissue. As such, information regarding chromosomal aberrations in this subtype of GCs is limited. In this study, we used representational difference